MeSH term
Frequency | Condition_Probility | Animals | 5 | 0.0 |
Female | 17 | 0.0 |
Humans | 36 | 0.0 |
Infant | 4 | 0.0 |
*Interleukin-12 | 4 | 100.0 |
Interleukins/*genetics | 4 | 14.0 |
Male | 16 | 0.0 |
Mice | 2 | 0.0 |
Adult | 15 | 0.0 |
Child | 12 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Genetic Predisposition to Disease | 9 | 0.0 |
Interferon Type II/*physiology | 2 | 3.0 |
Mutation | 3 | 0.0 |
Receptors, Interferon/genetics | 4 | 25.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Trans-Activators/genetics | 2 | 0.0 |
Adolescent | 9 | 0.0 |
Case-Control Studies | 7 | 0.0 |
Diabetes Mellitus, Type 1/epidemiology/*genetics | 2 | 9.0 |
Gene Frequency | 7 | 0.0 |
Haplotypes | 2 | 0.0 |
Interleukin-12/*genetics | 14 | 63.0 |
*Polymorphism, Genetic | 10 | 0.0 |
Alleles | 7 | 0.0 |
*Genetic Predisposition to Disease | 3 | 0.0 |
HLA-DQ Antigens/genetics | 2 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Child, Preschool | 4 | 0.0 |
Haplotypes/genetics | 3 | 0.0 |
Pedigree | 3 | 0.0 |
Phenotype | 4 | 0.0 |
Aged | 7 | 0.0 |
Gene Frequency/genetics | 2 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Japan | 3 | 0.0 |
Middle Aged | 9 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
3' Untranslated Regions/*genetics | 3 | 8.0 |
Diabetes Mellitus, Type 1/*genetics | 5 | 2.0 |
Genotype | 10 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Chromosomes, Human, Pair 5/*genetics | 2 | 2.0 |
Cohort Studies | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Introns | 2 | 0.0 |
3' Untranslated Regions | 3 | 2.0 |
Chromosome Mapping | 4 | 0.0 |
Chromosomes, Artificial, Yeast | 3 | 0.0 |
*Chromosomes, Human, Pair 5 | 5 | 2.0 |
Gene Dosage | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Myelodysplastic Syndromes/*genetics | 3 | 4.0 |
Physical Chromosome Mapping | 2 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
*Antiretroviral Therapy, Highly Active | 2 | 0.0 |
CD4 Lymphocyte Count | 2 | 0.0 |
HIV Infections/*drug therapy/genetics | 2 | 28.0 |
HIV-1/*genetics | 2 | 0.0 |
Interleukin-1/*genetics | 2 | 2.0 |
RNA, Viral/blood | 2 | 0.0 |
T-Lymphocyte Subsets | 2 | 1.0 |
Viral Load | 2 | 0.0 |
Viremia/*genetics | 2 | 100.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Sequence Tagged Sites | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Age of Onset | 2 | 0.0 |
Protein Subunits/*genetics | 4 | 21.0 |
Heterozygote | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
